Thomas Wilkinson

Thomas Wilkinson is a seasoned venture capitalist and entrepreneur with extensive experience in the tech and healthcare sectors. As the Managing Partner at Ollin Ventures since January 2018, Thomas has been instrumental in launching The Atom Fund to invest in pre-seed and seed companies, focusing on enterprise software and health tech. Thomas co-founded and serves as CEO of NeuroNova, a holistic mental wellness solution utilizing mechanical stimulation for enhancing dopamine production. Additionally, Thomas holds the position of Head of Growth and Board Member at Monovo, overseeing initiatives for direct health care solutions. Thomas is also involved as an investor and consultant in several companies, demonstrating a commitment to innovation and proactive health care. Thomas studied Mechanical Engineering at Brigham Young University and is currently pursuing Executive Education at Harvard Business School.